D8 Holdings Corp SPACquired Vicarious Surgical Inc
Company logo

DEH - D8 Holdings Corp.

NYSE -> Financial Services -> Shell Companies
Central, Hong Kong
Type: Equity

DEH price evolution
DEH
(in millions $) 29 Jul 2021 30 Apr 2021 30 Jan 2021 29 Oct 2020
Current assets
Cash $0.24 $1.03 $1.1 $1.18
Short term investments
Net receivables
Inventory
Total current assets $0.28 $1.09 $1.23 $1.38
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets $345.27 $345.26 $345.19 $345.09
Total investments
Total assets $345.54 $346.35 $346.42 $346.47
Current liabilities
Accounts payable $0.08 $0.06 $0.01 $0.04
Deferred revenue
Short long term debt
Total current liabilities $2.17 $1.51 $0.13 $0.13
Long term debt
Total noncurrent liabilities $338.37 $339.84 $341.3 $341.34
Total debt
Total liabilities $340.54 $341.35 $341.42 $341.47
Shareholders' equity
Retained earnings -$33.68 -$12.65 -$9.46 -$0.12
Other shareholder equity -$0
Total shareholder equity
(in millions $) 30 Jan 2021 30 Jan 2020
Current assets
Cash $1.1
Short term investments
Net receivables
Inventory
Total current assets $1.23
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets $345.19
Total investments
Total assets $346.42
Current liabilities
Accounts payable $0.01
Deferred revenue
Short long term debt
Total current liabilities $0.13
Long term debt
Total noncurrent liabilities $341.3
Total debt
Total liabilities $341.42
Shareholders' equity
Retained earnings -$9.46
Other shareholder equity
Total shareholder equity
(in millions $) 29 Jul 2021 30 Apr 2021 30 Jan 2021 29 Oct 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1.47 $1.53 $0.18
Operating income -$1.47 -$1.53 -$0.18
Income from continuing operations
EBIT
Income tax expense
Interest expense
Net income
Net income -$21.03 -$3.18 -$0.09
Income (for common shares)
(in millions $) 30 Jan 2021 30 Jan 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $0.35
Operating income -$0.35
Income from continuing operations
EBIT
Income tax expense
Interest expense
Net income
Net income -$9.46
Income (for common shares)
(in millions $) 29 Jul 2021 30 Apr 2021 30 Jan 2021 29 Oct 2020
Net income -$24.21 -$3.18
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$0.86 -$0.07
Investing activities
Capital expenditures
Investments
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents -$0.86 -$0.07
(in millions $) 30 Jan 2021 30 Jan 2020
Net income -$9.46
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$0.43
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$345
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $346.52
Effect of exchange rate
Change in cash and equivalents $1.1
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding 43.13M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share 0.01
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 0.13
Quick ratio N/A